» Articles » PMID: 26029648

Top Five Medical Innovations in China Mainland Since Xinhai Revolution [1911]: Results of AME Survey-002

Overview
Specialty Radiology
Date 2015 Jun 2
PMID 26029648
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This survey aims to scrutinize important medical innovations in Chinese mainland since Xinhai (Hsin-hai) revolution in 1911, which marked the end of Manchurian imperial rule and the beginning of China's republican era.

Methods: An online cross-sectional survey was carried out during the period of Dec 29, 2014 to Feb 5, 2015, totaling 37 days. The survey was conducted on the platform provided by DXY (www.dxy.cn), which is the largest medical and paramedical related website in China. An email was sent to all DXY registered users to invite them to participate in a 5-minute survey. The participants were asked to nominate up to four important medical innovations in China mainland since Xinhai revolution. The participant could select 'zero' which means he/she felt there was no important medical innovations, or he/she did not know important medical innovations. It was noted that important medical innovations refer to (I) those with practical and almost immediate significance to improve healthcare; (II) should not only be introducing western technique to China, but those involve major improvement of existing western techniques count; (III) should not be those with important theoretical discovery but did not have almost immediate significance to improve healthcare.

Results: In total 1,513 DXY users participated in the voting. Totally 489 (32.3%), 441 (29.1%), 342 (22.6%), 150 (9.9%), 91 (6.0%) participants provided 0, 1, 2, 3, 4 nominations respectively. (I) Artemisine (Qinghaosu) for malaria treatment (Project 523 team, 1972); (II) arsenic Trioxide (As2O3) for acute promyelocytic leukemia (APL) treatment (ZHANG Ting-Dong and colleagues, 1970s); (III) limb re-plantation (CHEN Zhong-Wei and colleagues, 1963); (IV) all-trans retinoic acid (ATRA) for APL treatment (WANG Zhen-Yi and colleagues, 1988); and (V) Wu's mask for plague prevention (WU Lien-The, 1910), were voted as the top five innovations in China mainland since Xinhai revolution, with 375, 96, 91, 53, and 8 votes respectively.

Conclusions: In this voting exercise, five achievements were voted as top innovations in China mainland since Xinhai revolution. However, only ATRA for APL treatment was accomplished after the ending of Great Proletarian Cultural Revolution in year 1976 in China.

Citing Articles

Successfully Replanted An Amputated Hand: A Case Report.

Murrad K, Rashidi M, Altamimi A Cureus. 2022; 14(3):e23366.

PMID: 35475050 PMC: 9018946. DOI: 10.7759/cureus.23366.


The role of Chaoyang People's Hospital for the development of trioxide as an effective treatment for acute promyelocytic leukemia treatment.

Wang Y Quant Imaging Med Surg. 2015; 5(5):791.

PMID: 26682151 PMC: 4671967. DOI: 10.3978/j.issn.2223-4292.2015.10.05.


AME survey-003 A1-part1: in current China, do you regret you joined the medical profession.

Wang Y, L Y Quant Imaging Med Surg. 2015; 5(5):765-73.

PMID: 26682145 PMC: 4671960. DOI: 10.3978/j.issn.2223-4292.2015.10.07.


Why China is currently underperforming in medical innovation and what China can do about it?-Part III: social psychology and evolutionary psychology perspectives.

Wang Y Quant Imaging Med Surg. 2015; 5(4):494-502.

PMID: 26435912 PMC: 4559978. DOI: 10.3978/j.issn.2223-4292.2015.05.01.


Why China is currently underperforming in medical innovation and what China can do about it?-Part II.

Wang Y Quant Imaging Med Surg. 2015; 5(3):335-9.

PMID: 26029635 PMC: 4426112. DOI: 10.3978/j.issn.2223-4292.2015.04.03.


References
1.
Chen Z, Hu T . A reconstructed digit by transplantation of a second toe for control of an electromechanical prosthetic hand. Microsurgery. 2002; 22(1):5-10. DOI: 10.1002/micr.22002. View

2.
Tallman M, Andersen J, Schiffer C, Appelbaum F, Feusner J, Woods W . All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood. 2002; 100(13):4298-302. DOI: 10.1182/blood-2002-02-0632. View

3.
SANGER F, THOMPSON E . The amino-acid sequence in the glycyl chain of insulin. II. The investigation of peptides from enzymic hydrolysates. Biochem J. 1953; 53(3):366-74. PMC: 1198158. DOI: 10.1042/bj0530366. View

4.
Huang M, Ye Y, Chen S, Chai J, Lu J, Zhoa L . Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988; 72(2):567-72. View

5.
Chomienne C, Ballerini P, Balitrand N, Amar M, Bernard J, Boivin P . Retinoic acid therapy for promyelocytic leukaemia. Lancet. 1989; 2(8665):746-7. DOI: 10.1016/s0140-6736(89)90812-x. View